GLAXOSMITHKLINE CONSUMER

7231.4 -56.75 (-0.78%) Sell

GSKCONS continues its fall as more investors loose confidence

13 min read

GLAXOSMITHKLINE CONSUMER showed weakness on Friday. It fell by -0.78% to close at 7231.4. On a day when the overall market breadth was 71%, it closed higher than 48% of the market. In comparison, the benchmark NIFTY-50 index closed today at +0.02%.

[Themes containing GSKCONS]

GSKCONS showed a bullish trend over the last 3 months. During this period GSKCONS increased by +2.37% and saw a maximum drawdown of -7.38%. There was a long signal during this period which returned +3.0%.

Trend

GSKCONS has been underperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 6 Jan, 2016 to 26 Oct, 2017. Over the last 3 years and 1 month, GSKCONS underperformed the NIFTY-50 index on 51% days.

During the last three months GSKCONS delivered losses on 51% days. However, it still managed to end this period in a profit. It's best return during this period (of +3.84%) was on Monday, 3 Dec, 2018. While it's worst loss in the same period (of -3.12%) was on Thursday, 15 Nov, 2018. The longest stort-term trend during this period was 6 profitable days, which started on 11 Dec, 2018 and went on till 18 Dec, 2018. This bullish trend returned +4.07% to investors.

During the last year GSKCONS had 8 profitable months and 4 loss making months. GSKCONS returned profits in more months than NIFTY-50 index. GSKCONS significantly outperformed NIFTY-50 index in Aug 2018, when it returned +18.82% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. GSKCONS had a longer winning streak of profitable months than NIFTY-50 index. It went up in 3 straight months (from Oct 2018 to Dec 2018) during which period it delivered +9.43%.

How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.
-- Robert G. Allen

GSKCONS is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in GSKCONS's volatility from 19 Oct, 2018 to 15 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that GSKCONS has significant negative skewness in it's return distribution. This indicates that GSKCONS is very risky for short-term investment and can significantly underperform for long durations.

GSKCONS has more chance of extreme outcomes than the NIFTY-50 index. Therefore, GSKCONS must receive a lower allocation than NIFTY-50 in your portfolio. NIFTY-50 index usually has shorter drawdown period than GSKCONS.

Based on your interest in GSKCONS you may find it interesting to know that BATAINDIA, LTI and LTTS are mid caps that have all shown remarkable performance and qualify to be on every investor's watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter